---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-018849"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:21:56.608895+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor: preliminary Q4 net loss ~$300M, $310M goodwill impairment; launches financing for Rotech acquisition

## Summary
- Q4 prelim rev $2.67-2.70B; net loss $(288-311)M; adj EBITDA $135-140M; adj EPS $0.52-0.55.
- FY2024 prelim rev $10.67-10.70B; net loss $(355-378)M; adj EBITDA $520-525M; adj EPS $1.50-1.53.
- Non-cash goodwill impairment ~$310M in Apria division from stock decline, rates, contract pricing.
- Total debt reduced by over $240M in 2024; total debt ~$1.854-1.859B; net debt ~$1.805-1.810B.
- Commenced financing for previously announced Rotech acquisition; expected close 1H 2025.

## SEC filing metadata
- accession: 0001193125-25-018849
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/0001193125-25-018849-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/d872714d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-018849
- JSON: https://secwatch.observer/filing/0001193125-25-018849.json
- Plain text: https://secwatch.observer/filing/0001193125-25-018849.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.